Kintara Therapeutics, Inc.
Kintara Therapeutics, Inc. (KTRA) is a publicly traded company in the Unknown sector. Across all available filings, 8 corporate insiders have executed 27 transactions totaling $79.0K, demonstrating a bullish sentiment with $79.0K in net insider flow. The most recent transaction on Jun 1, 2023 involved a transaction of 59,800 shares valued at $0.
KTRA Insider Activity Summary
Who Is Buying KTRA Stock?
No significant insider buying has been recorded for KTRA in the recent period.
Who Is Selling KTRA Stock?
No significant insider selling has been recorded for KTRA in the recent period.
Is Kintara Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for KTRA is bullish with an Insider Alignment Score of 100/100 and a net flow of $79.0K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
KTRA Frequently Asked Questions
Understanding KTRA Insider Activity
Insider trading at Kintara Therapeutics, Inc. (KTRA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 8 insiders are actively trading KTRA stock, having executed 27 transactions in the past 90 days. The most active insider is Saiid Zarrabian (Executive), who has made 2 transactions totaling $31.4K.
Related Tools
Track Kintara Therapeutics, Inc. Insider Activity
Get notified when executives and directors at KTRA file new Form 4 transactions